Annual EBITDA
-$30.49 M
-$19.46 M-176.49%
31 December 2021
Summary:
Statera Biopharma annual earnings before interest, taxes, depreciation & amortization is currently -$30.49 million, with the most recent change of -$19.46 million (-176.49%) on 31 December 2021. During the last 3 years, it has fallen by -$19.46 million (-176.49%). STAB annual EBITDA is now -983.34% below its all-time high of -$2.81 million, reached on 31 December 2019.STAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.35 M
+$1.37 M+50.24%
30 September 2022
Summary:
Statera Biopharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.35 million, with the most recent change of +$1.37 million (+50.24%) on 30 September 2022. STAB quarterly EBITDA is now -121.39% below its all-time high of -$611.90 thousand, reached on 01 March 2020.STAB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$18.61 M
+$8.15 M+30.45%
30 September 2022
Summary:
Statera Biopharma TTM earnings before interest, taxes, depreciation & amortization is currently -$18.61 million, with the most recent change of +$8.15 million (+30.45%) on 30 September 2022. STAB TTM EBITDA is now -2941.92% below its all-time high of -$611.90 thousand, reached on 01 March 2020.STAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STAB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -176.5% | +85.8% | +26.6% |
| 5 y5 years | - | - | - |
STAB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -176.5% | at low | at high | +85.8% | at high | +38.7% |
| 5 y | 5 years | -983.3% | at low | -121.4% | +85.8% | -2941.9% | +38.7% |
| alltime | all time | -983.3% | at low | -121.4% | +85.8% | -2941.9% | +38.7% |
Statera Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$1.35 M(-50.2%) | -$18.61 M(-30.5%) |
| June 2022 | - | -$2.72 M(-58.1%) | -$26.76 M(-11.9%) |
| Mar 2022 | - | -$6.49 M(-19.3%) | -$30.36 M(+4.5%) |
| Dec 2021 | -$30.49 M | -$8.04 M(-15.4%) | -$29.06 M(+14.5%) |
| Sept 2021 | - | -$9.50 M(+50.4%) | -$25.37 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$6.32 M(+21.7%) | -$21.81 M(+40.8%) |
| Mar 2021 | - | -$5.19 M(+19.3%) | -$15.49 M(+42.0%) |
| Dec 2020 | -$11.03 M(+291.8%) | -$4.35 M(-26.8%) | -$10.91 M(+66.4%) |
| Sept 2020 | - | -$5.95 M(+871.9%) | -$6.56 M(+971.9%) |
| Mar 2020 | - | -$611.90 K | -$611.90 K |
| Dec 2019 | -$2.81 M | - | - |
FAQ
- What is Statera Biopharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Statera Biopharma?
- What is Statera Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Statera Biopharma?
- What is Statera Biopharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Statera Biopharma?
What is Statera Biopharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of STAB is -$30.49 M
What is the all time high annual EBITDA for Statera Biopharma?
Statera Biopharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$2.81 M
What is Statera Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of STAB is -$1.35 M
What is the all time high quarterly EBITDA for Statera Biopharma?
Statera Biopharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$611.90 K
What is Statera Biopharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of STAB is -$18.61 M
What is the all time high TTM EBITDA for Statera Biopharma?
Statera Biopharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$611.90 K